84 related articles for article (PubMed ID: 22265920)
1. [Complications associated with sentinel lymph node biopsy for cutaneous melanoma. A retrospective study of 127 patients].
Duvernay A; Henault B; Danino MA; Trost O; Dalac S; Aubriot-Lorton MH; Zwetyenga N
Ann Chir Plast Esthet; 2012 Apr; 57(2):151-7. PubMed ID: 22265920
[TBL] [Abstract][Full Text] [Related]
2. Is completion lymphadenectomy after a positive sentinel lymph node biopsy for cutaneous melanoma always necessary?
Elias N; Tanabe KK; Sober AJ; Gadd MA; Mihm MC; Goodspeed B; Cosimi AB
Arch Surg; 2004 Apr; 139(4):400-4; discussion 404-5. PubMed ID: 15078708
[TBL] [Abstract][Full Text] [Related]
3. [Feasibility and technical problems of sentinel node analysis in melanoma].
Mebazaa A; Kerob D; Toubert ME; Verola O; Servant JM; Baccard M; Billotey C; Bustamante K; Vandici FO; Basset-Seguin N; Ollivaud L; Morel P; Lebbé C
Ann Chir Plast Esthet; 2007 Feb; 52(1):14-23. PubMed ID: 17141391
[TBL] [Abstract][Full Text] [Related]
4. Histological features of melanoma sentinel lymph node metastases associated with status of the completion lymphadenectomy and rate of subsequent relapse.
Govindarajan A; Ghazarian DM; McCready DR; Leong WL
Ann Surg Oncol; 2007 Feb; 14(2):906-12. PubMed ID: 17136471
[TBL] [Abstract][Full Text] [Related]
5. Morbidity and recurrence after completion lymph node dissection following sentinel lymph node biopsy in cutaneous malignant melanoma.
Guggenheim MM; Hug U; Jung FJ; Rousson V; Aust MC; Calcagni M; Künzi W; Giovanoli P
Ann Surg; 2008 Apr; 247(4):687-93. PubMed ID: 18362633
[TBL] [Abstract][Full Text] [Related]
6. Predictors of nonsentinel lymph node positivity in patients with a positive sentinel node for melanoma.
Sabel MS; Griffith K; Sondak VK; Lowe L; Schwartz JL; Cimmino VM; Chang AE; Rees RS; Bradford CR; Johnson TM
J Am Coll Surg; 2005 Jul; 201(1):37-47. PubMed ID: 15978442
[TBL] [Abstract][Full Text] [Related]
7. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.
Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W
Ann Surg Oncol; 2006 Dec; 13(12):1655-63. PubMed ID: 17016755
[TBL] [Abstract][Full Text] [Related]
8. Prediction of nonsentinel lymph node involvement in patients with a positive sentinel lymph node in malignant melanoma.
Page AJ; Carlson GW; Delman KA; Murray D; Hestley A; Cohen C
Am Surg; 2007 Jul; 73(7):674-8; discussion 678-9. PubMed ID: 17674939
[TBL] [Abstract][Full Text] [Related]
9. [Sentinel lymph node biopsy in patients with cutaneous malignant melanoma].
Gad D; Sjøgren P
Ugeskr Laeger; 2003 Jun; 165(25):2567-70. PubMed ID: 12854268
[TBL] [Abstract][Full Text] [Related]
10. Sentinel lymph node micrometastasis may predict non-sentinel involvement in cutaneous melanoma patients.
Glumac N; Hocevar M; Zadnik V; Snoj M
J Surg Oncol; 2008 Jul; 98(1):46-8. PubMed ID: 18452214
[TBL] [Abstract][Full Text] [Related]
11. Sentinel lymph nodes containing very small (<0.1 mm) deposits of metastatic melanoma cannot be safely regarded as tumor-negative.
Murali R; DeSilva C; McCarthy SW; Thompson JF; Scolyer RA
Ann Surg Oncol; 2012 Apr; 19(4):1089-99. PubMed ID: 22271204
[TBL] [Abstract][Full Text] [Related]
12. Inguinal node dissection for melanoma in the era of sentinel lymph node biopsy.
Sabel MS; Griffith KA; Arora A; Shargorodsky J; Blazer DG; Rees R; Wong SL; Cimmino VM; Chang AE
Surgery; 2007 Jun; 141(6):728-35. PubMed ID: 17560249
[TBL] [Abstract][Full Text] [Related]
13. Validation of a scoring system to predict non-sentinel lymph node metastasis in melanoma.
Cadili A; McKinnon G; Wright F; Hanna W; Macintosh E; Abhari Z; Dabbs K
J Surg Oncol; 2010 Mar; 101(3):191-4. PubMed ID: 20039281
[TBL] [Abstract][Full Text] [Related]
14. Prediction of nonsentinel lymph node metastasis in malignant melanoma.
Cadili A; Smylie M; Danyluk J; Dabbs K
J Surg Res; 2009 Jun; 154(2):324-9. PubMed ID: 19101696
[TBL] [Abstract][Full Text] [Related]
15. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection.
Debarbieux S; Duru G; Dalle S; Béatrix O; Balme B; Thomas L
Br J Dermatol; 2007 Jul; 157(1):58-67. PubMed ID: 17501957
[TBL] [Abstract][Full Text] [Related]
16. Influence of sentinel lymph node tumor burden on survival in melanoma.
Francischetto T; Spector N; Neto Rezende JF; de Azevedo Antunes M; de Oliveira Romano S; Small IA; Gil Ferreira C
Ann Surg Oncol; 2010 Apr; 17(4):1152-8. PubMed ID: 20087785
[TBL] [Abstract][Full Text] [Related]
17. In transit/local recurrences in melanoma patients after sentinel node biopsy and therapeutic lymph node dissection.
Rutkowski P; Nowecki ZI; Zurawski Z; Dziewirski W; Nasierowska-Guttmejer A; Switaj T; Ruka W
Eur J Cancer; 2006 Jan; 42(2):159-64. PubMed ID: 16324835
[TBL] [Abstract][Full Text] [Related]
18. Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma.
Gannon CJ; Rousseau DL; Ross MI; Johnson MM; Lee JE; Mansfield PF; Cormier JN; Prieto VG; Gershenwald JE
Cancer; 2006 Dec; 107(11):2647-52. PubMed ID: 17063497
[TBL] [Abstract][Full Text] [Related]
19. Melanoma patients with positive sentinel nodes who did not undergo completion lymphadenectomy: a multi-institutional study.
Wong SL; Morton DL; Thompson JF; Gershenwald JE; Leong SP; Reintgen DS; Gutman H; Sabel MS; Carlson GW; McMasters KM; Tyler DS; Goydos JS; Eggermont AM; Nieweg OE; Cosimi AB; Riker AI; G Coit D
Ann Surg Oncol; 2006 Jun; 13(6):809-16. PubMed ID: 16604476
[TBL] [Abstract][Full Text] [Related]
20. Optimal detection of sentinel lymph node metastases by intraoperative radioactive threshold and molecular analysis in patients with melanoma.
Manca G; Romanini A; Pellegrino D; Borsò E; Rondini M; Orlandini C; Zucchi V; Pasqualetti F; Mariani G
J Nucl Med; 2008 Nov; 49(11):1769-75. PubMed ID: 18927334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]